|
English
|
正體中文
|
简体中文
|
2808638
|
|
???header.visitor??? :
26763010
???header.onlineuser??? :
239
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"langley richard g"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-09-20T06:07:34Z |
Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis
|
Blauvelt, Andrew; TSEN-FANG TSAI; Langley, Richard G; Miller, Megan; Shen, Yaung-Kaung; You, Yin; Yang, Ya-Wen; Papp, Kim A; Puig, Luis |
| 國立臺灣大學 |
2014 |
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
|
Langley, Richard G.; Elewski, Boni E.; Lebwohl, Mark; Reich, Kristian; Griffiths, Christopher E. M.; Papp, Kim; Puig, Lluis; Nakagawa, Hidemi; Spelman, Lynda; Sigurgeirsson, Bardur; Rivas, Enrique; Tsai, Tsen-Fang; Wasel, Norman; Tyring, Stephen; Salko, Thomas; Hampele, Isabelle; Notter, Marianne; Karpov, Alexander; Helou, Silvia; Papavassilis, Charis; 蔡呈芳 |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
